Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Virucidal activity of a GT-rich oligonucleotide against herpes simplex virus mediated by glycoprotein B.

Shogan B, Kruse L, Mulamba GB, Hu A, Coen DM.

J Virol. 2006 May;80(10):4740-7. Erratum in: J Virol. 2011 Feb;85(4):1909.

2.

Virologic and enzymatic studies revealing the mechanism of K65R- and Q151M-associated HIV-1 drug resistance towards emtricitabine and lamivudine.

Feng JY, Myrick FT, Margot NA, Mulamba GB, Rimsky L, Borroto-Esoda K, Selmi B, Canard B.

Nucleosides Nucleotides Nucleic Acids. 2006;25(1):89-107.

PMID:
16440988
3.

A recombinant human cytomegalovirus with a large deletion in UL97 has a severe replication deficiency.

Prichard MN, Gao N, Jairath S, Mulamba G, Krosky P, Coen DM, Parker BO, Pari GS.

J Virol. 1999 Jul;73(7):5663-70.

4.
5.

Human cytomegalovirus mutant with sequence-dependent resistance to the phosphorothioate oligonucleotide fomivirsen (ISIS 2922).

Mulamba GB, Hu A, Azad RF, Anderson KP, Coen DM.

Antimicrob Agents Chemother. 1998 Apr;42(4):971-3.

6.

Penciclovir and pathogenesis phenotypes of drug-resistant Herpes simplex virus mutants.

Pelosi E, Mulamba GB, Coen DM.

Antiviral Res. 1998 Jan;37(1):17-28.

PMID:
9497069

Supplemental Content

Loading ...
Support Center